1222 FIRST CLINICAL PYELOPLASTY SERIES EMPLOYING THE NOVEL DA VINCI SINGLE SITE ROBOTIC PLATFORM FOR THE SURGICAL TREATMENT OF URETERO-PELVIC JUNCTION OBSTRUCTION: FEASIBILITY AND PRELIMINARY RESULTS

2012 ◽  
Vol 187 (4S) ◽  
Author(s):  
Andrea Cestari ◽  
Nicolò Buffi ◽  
Giovanni Lughezzani ◽  
Alessandro Larcher ◽  
Giuliana Lista ◽  
...  
2012 ◽  
Vol 11 (1) ◽  
pp. eV40-eV40a
Author(s):  
N.M. Buffi ◽  
A. Cestari ◽  
M. Lazzeri ◽  
G. Lughezzani ◽  
G. Lista ◽  
...  

2014 ◽  
Vol 55 (6) ◽  
pp. 380 ◽  
Author(s):  
Christos Komninos ◽  
Patrick Tuliao ◽  
Dae Keun Kim ◽  
Young Deuk Choi ◽  
Byung Ha Chung ◽  
...  

Hernia ◽  
2016 ◽  
Vol 21 (3) ◽  
pp. 383-389 ◽  
Author(s):  
A. Cestari ◽  
A. C. Galli ◽  
M. N. Sangalli ◽  
M. Zanoni ◽  
M. Ferrari ◽  
...  

Author(s):  
Andrea Cestari ◽  
Matteo Ferrari ◽  
Matteo Zanoni ◽  
Mattia Sangalli ◽  
Massimo Ghezzi ◽  
...  

2012 ◽  
Vol 26 (8) ◽  
pp. 971-974 ◽  
Author(s):  
Casey A. Seideman ◽  
Yung K. Tan ◽  
Stephen Faddegon ◽  
Samuel K. Park ◽  
Sara L. Best ◽  
...  

2021 ◽  
Vol 10 (8) ◽  
pp. 1563
Author(s):  
Ching-Chia Li ◽  
Tsu-Ming Chien ◽  
Ming-Ru Lee ◽  
Hsiang-Ying Lee ◽  
Hung-Lung Ke ◽  
...  

Currently, over 80% of radical prostatectomies have been performed with the da Vinci Surgical System. In order to improve the aesthetic outlook and decrease the morbidity of the operation, the new da Vinci Single Port (SP) system was developed in 2018. However, one major problem is the SP system is still not available in most countries. We aim to present our initial experience and show the safety and feasibility of the single-site robotic-assisted radical prostatectomy (LESS-RP) using the da Vinci Single-Site platform. From June 2017 to January 2020, 120 patients with localized prostate cancer (stage T1–T3b) at Kaohsiung Medical University Hospital were included in this study. We describe our technique and report our initial results of LESS-RP using the da Vinci Si robotic system. Preoperative, intraoperative and postoperative patient variables were recorded. Prostate-specific antigen (PSA)-free survival was also analyzed. A total of 120 patients were enrolled in the study. The median age of patients was 68 years (IQR 63–71), with a median body mass index of 25 kg/m2 (IQR 23–27). The median PSA value before operation was 10.7 ng/mL (IQR 7.9–21.1). The median setup time for creat-ing the extraperitoneal space and ports document was 25 min (IQR 18–34). The median robotic console time and operation time were 135 min (IQR 110–161) and 225 min (IQR 197–274), respectively. Median blood loss was 365 mL (IQR 200–600). There were 11 (9.2%) patients who experienced complications (Clavien–Dindo classification Gr II). The me-dian catheter duration was 8 days (IQR 7–9), with a median of 10 days (IQR 7–11) of hospital stay. The PSA free-survival rate was 86% at a median 19 months (IQR 6–28) of follow up. Robotic radical prostatectomy using the da Vinci Single-Site platform system is safe and feasible, with acceptable outcomes.


Sign in / Sign up

Export Citation Format

Share Document